were used with the for some results of investment another costs. All published costs were study and presented in discussed Euros some (EUR). limitations of their study. Loane To Patients The Diagnostic Comparator: 2000 evaluate with effectiveness concordances: The selection the and cost -Primary of the clinical evidences diagnosis 51/84 comparator efficacy were both (60.7%) was and versus from a part appropriate. -Aggregated real-time of -Time diagnosis 74/84 of randomised a (88.1%) real-time controlled Validity of the and for trial estimate of referral same patients conducted in measure of in the Clinical outcomes as the with all the first 12 effectiveness view of (hospital length skin months of their appointment of the the UK treating required) clinical The GP. trial trial. Real-time: N=43 effectiveness along evidence came with a Patient SAF: N=66 from a clinical clinical clinical trial, which trial. outcomes was and costs of Consultation time appropriate the RT (mean±SD) for the study consultation Real-time: question. The
were used for some investment costs. All costs were presented in Euros (EUR). with the results of another published study and discussed some limitations of their study. Loane 2000 To evaluate the clinical efficacy and of real-time and along with a clinical trial. Patients with a referral in the view of their treating GP. -Time the same as the length of the clinical trial versus real-time for patients with all skin The effectiveness and cost evidences were both from a part of randomised controlled trial conducted in the first 12 months of the UK trial. Patient clinical outcomes and costs of the RT consultation Diagnostic concordances: -Primary diagnosis 51/84 (60.7%) -Aggregated diagnosis 74/84 (88.1%) Clinical outcomes (hospital appointment required) Real-time: N=43 SAF: N=66 Consultation time (mean±SD) Real-time: Comparator: The selection of the comparator was appropriate. Validity of estimate of measure of effectiveness The effectiveness evidence came from a clinical trial, which was appropriate for the study question. The
1360%20-%20FinalAssessmentReport%20-accessible.docx